Extra Chromosomes and Chromosomal Instability Trigger Common Childhood Cancer
B-cell acute lymphoblastic leukaemia is the most common form of childhood cancer. In this type of cancer, which affects blood cells, one of the most common abnormalities is the presence of cells with an excess of chromosomes (hyperdiploidy), a condition that leads to chromosomal instability. Now, a study published in Cell Reports reveals that this chromosomal instability caused by hyperdiploidy reduces the proliferation of the affected cells, delays their differentiation an
2 days ago
Beyond Survival: The Push to Protect Future Fertility for Pediatric Patients with Cancer
The field of pediatric oncofertility focuses on efforts to protect and preserve a patient’s fertility potential and reproductive hormone function from the effects of cancer treatments like chemotherapy and radiation — two considerations known to be extremely important for overall health and well-being. Read more: https://news.cuanschutz.edu/accords/beyond-survival-the-push-to-protect-future-fertility-for-pediatric-patients-with-cancer
3 days ago
A 13-year-old boy has become the first person to be cured of this deadly brain cancer
Diagnosed with DIPG at age six, Lucas’ doctor Jacques Grill told Lucas’ parents, Cedric and Olesja, that he was unlikely to live very long. Instead of giving up hope, Cedric and Olesja flew Lucas to France to participate in a clinical trial called BIOMEDE, which tested new potential drugs against DIPG. Read more: https://www.upworthy.com/first-person-cured-of-dipg-ex1/
4 days ago
Palliative Radiotherapy Provides Symptom Relief for Children
Hypofractionated palliative radiotherapy (PRT) effectively relieves pain in children with cancer, according to findings published in the EJC Pediatric Oncology . Researchers added that treatment was well-tolerated even after palliative reirradiation to the same anatomic site. Read more: https://www.cancertherapyadvisor.com/news/palliative-radiotherapy-symptom-relief-children/
5 days ago
Shields and bodyguards: Scientists uncover the hidden defenses of a deadly childhood cancer
The University of Queensland researchers used cutting-edge technology to map the biology of neuroblastoma—a cancer that typically develops in children under the age of 5—finding a hidden "shield" the tumors use as protection. Certain immune cells surrounding the tumor were also discovered to act as "bodyguards" for the cancer. Read more here: https://medicalxpress.com/news/2026-03-shields-bodyguards-scientists-uncover-hidden.html
6 days ago
An avatar to study pediatric brain cancer may soon be a reality
Now, results obtained by a study led by the University of Trento in collaboration with Bambino Gesù Children's Hospital in Rome may pave a path to an organoid that could be used to study two common, aggressive childhood brain cancers. Read more: https://medicalxpress.com/news/2026-03-avatar-pediatric-brain-cancer-reality.html
Apr 10
Pig semen eye drops may treat rare childhood eye cancer, study says
Researchers have created experimental eye drops that use a molecule derived from pig semen that could treat a rare form of cancer, according to a recent study. Read more: https://www.fox13news.com/news/pig-semen-eye-drops-may-treat-rare-childhood-eye-cancer-study-says
Apr 9
Artificial intelligence learns to make sense of childhood cancer survivors’ health care needs
Artificial intelligence (AI) could help physicians determine if survivors of childhood cancer need extra support — and the more information included in AI prompting, the better its performance. Read more: https://www.eurekalert.org/news-releases/1121751
Apr 8
NUTM1 rearrangements cause a highly treatable form of infant leukemia
Researchers in Japan find that B-cell acute lymphoblastic leukemia with NUTM1 gene rearrangements is a unique form of the disease, with a distinct pattern of gene activity and gene regulation that is highly sensitive to chemotherapy. Read more: https://www.asiaresearchnews.com/content/nutm1-rearrangements-cause-highly-treatable-form-infant-leukemia
Apr 1
Researchers uncovered the driving force behind lethal infant brain tumor
An international team led by researchers at Baylor College of Medicine, Texas Children’s Hospital, McGill University and University of Pittsburgh School of Medicine has discovered what drives the growth of a lethal pediatric brain tumor called Posterior Fossa Type A (PFA) ependymoma. Read more: https://www.eurekalert.org/news-releases/1121004
Mar 31

